Reckitt Benckiser Group PLC (LSE:RKT) is reportedly in negotiations with potential buyers to offload its £6 billion homecare division, which includes well-known brands such as Air Wick, Mortein, Calgon, and Cillit Bang. Bloomberg has reported these discussions, which align with the company's broader strategy to streamline its portfolio.
In July, Reckitt announced its intention to focus on high-margin 'Powerbrands,' including Strepsils, Gaviscon, Nurofen, Dettol, Finish, and Durex, among others in the consumer health and hygiene sectors. This strategic shift aims to simplify and sharpen the company's operations by shedding non-core products.
Morgan Stanley (NYSE:MS) is expected to lead the formal sale process, which is anticipated to commence within the next few months. This move is part of Reckitt’s efforts to enhance its focus on more profitable areas of its business. In addition to the homecare division, the company is also evaluating the potential disposal of its Mead Johnson Nutrition business, which encompasses brands such as Enfamil and Nutramigen.
Reckitt has faced difficulties in recent years, leading to a significant decline in its share price. Over the past 12 months, the company has experienced a double-digit drop in its stock value. The challenges are reflected in its financial performance, with net revenues falling by 3.7% year-on-year. Additionally, operating profit margins have tightened by 20 basis points in the first half of Reckitt’s current financial year.
The decision to divest these divisions comes amid a strategic realignment aimed at focusing on areas with higher growth potential and profitability. By concentrating on its core brands, Reckitt seeks to improve its overall financial performance and operational efficiency.
The proposed sales are seen as part of a broader trend among major consumer goods companies to streamline their portfolios and concentrate on their most lucrative and strategic assets. This approach is intended to position Reckitt more favorably in the competitive consumer goods market and to address the pressures that have impacted its growth and profitability in recent years.
The outcome of these discussions and the impact on Reckitt’s future performance will be closely watched by market participants as the company moves forward with its restructuring plans.